Over the past year, we have carefully considered whether — and how — life sciences companies can use AI tools in their clinical development ...
MintNeuro, a pioneer of scalable, low-power semiconductor technology for neural implant applications, and Motif Neurotech, a therapeutic brain-computer interface (BCI) company developing miniature ...
Organizations must adapt to technological advancements by rethinking business models and embracing new software development methodologies like agile and waterfall. Exploring COTS, SaaS, IaaS, PaaS, ...
Motif Neurotech wins FDA clearance for first human trial of a wireless brain implant targeting treatment-resistant depression ...
Artificial intelligence is starting to move beyond support roles and into the core of scientific discovery. In this episode ...
Computer vision is driving healthcare gains in imaging, safety, staff well-being, and efficiency, but scaling it requires ...
Artificial intelligence has moved from the back office to the witness stand, becoming the foundation for expert testimony and ...
Embed technical assurance into vendor contracts, requiring evidence of performance/robustness/bias testing, transparency ...
The company's devices use FDA-cleared low-level laser and LED light therapy to stimulate hair follicles. Three main hair growth systems are available: Essential, Professional, and Elite. Customers can ...
The FDA has accomplished one of the most important regulatory overhauls in decades by replacing the traditional Quality System Regulation (QSR) with the Quality Management System Regulation (QMSR).
37 practitioners. 5 pharma companies. One shared conviction: legacy computerized system validation no longer serves the industry it was built to protect The validation framework that protected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results